SPLITOAK STRATEGIES LLC Consulting firm 300 New Jersey Avenue, NW Suite 900 Washington, DC 20001 USA |
Lobbying on the following issues:
MEDICARE/MEDICAID TAXATION/INTERNAL REVENUE CODE HEALTH ISSUES Medicare Advantage program improvements. Improvements in federal programs to provide better management and coordination of patient care and outcomes. - HR 1398 and S 172, Health Insurance Tax Relief Act of 2019 - Improving the performance of the health care system through better patient management and coordinated care. - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions Special Assistant to the Speaker for Policy Assistant to the President for Legislative Affairs Legislative Assistant Policy Analyst Assistant to the Speaker for Policy Special Assistant to the President for Legislative Affairs Policy Analyst Special Assistant to the President for Legislative Affairs Assistant to the Speaker for Policy Policy AnalystEgge, Sarah Kuehl Held the following Government positions Legislative Assistant, Sen. Bob Kerrey (1998-2000) Senior Budget Analyst, Senate Budget Committee (2001-2012) Deputy Staff Director, Joint Select Committee on Deficit Reduction (Fall 2011) Legislative Assistant to Sen. Bob Kerrey (1998-2000), Senior Budget Analyst to Senate Budget Committee (2001-2012), Deputy Staff Director to Joint Select Committee on Deficit Reduction (Fall 2011)
Foreign Entities: Foreign Entity Name: Fresenius Medical Care AG and Co. KGaA is the sole indirect owner of Fresenius Medical Care Holdings, Inc. (dba Fresenius Medical Care North America)Country : GERMANYContribution : $0 |
Lobbying on the following issues:
HEALTH ISSUES MEDICARE/MEDICAID TAXATION/INTERNAL REVENUE CODE Improving the performance of the health care system through better patient management and coordinated care, S 1895 - Medicare Advantage program improvements. Improvements in federal programs to provide better management and coordination of patient care and outcomes. S 1895 - HR 1398 and S 172, HR 3439, Health Insurance Tax Relief Act of 2019 - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions Special Assistant to the Speaker for Policy Assistant to the President for Legislative Affairs Legislative Assistant Policy Analyst Assistant to the Speaker for Policy Special Assistant to the President for Legislative Affairs Policy Analyst Special Assistant to the President for Legislative Affairs Assistant to the Speaker for Policy Policy AnalystEgge, Sarah Kuehl Held the following Government positions Legislative Assistant, Sen. Bob Kerrey (1998-2000) Senior Budget Analyst, Senate Budget Committee (2001-2012) Deputy Staff Director, Joint Select Committee on Deficit Reduction (Fall 2011) Legislative Assistant to Sen. Bob Kerrey (1998-2000), Senior Budget Analyst to Senate Budget Committee (2001-2012), Deputy Staff Director to Joint Select Committee on Deficit Reduction (Fall 2011)
Foreign Entities: Foreign Entity Name : Roivant Sciences Holdings Ltd.Country : UNITED KINGDOMContribution : $0 - Foreign Entity Name : Roivant Sciences Ltd.Country : BERMUDAContribution : $0 - |
Lobbying on the following issues:
HEALTH ISSUES MEDICARE/MEDICAID Improving the performance of the health care system through better patient management and coordinated care, S 1895, HR 5826, HR5800 and HR 3630, reform for out of network bills, health care oversight - Medicare Advantage program improvements. Improvements in federal programs to provide better management and coordination of patient care and outcomes. S 1895 - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions Special Assistant to the Speaker for Policy Assistant to the President for Legislative Affairs Legislative Assistant Policy Analyst Assistant to the Speaker for Policy Special Assistant to the President for Legislative Affairs Policy AnalystEgge, Sarah Kuehl Held the following Government positions Legislative Assistant, Sen. Bob Kerrey (1998-2000) Senior Budget Analyst, Senate Budget Committee (2001-2012) Deputy Staff Director, Joint Select Committee on Deficit Reduction (Fall 2011)
Foreign Entities: Foreign Entity Name: Attestor Ltd.Country : UNITED KINGDOMContribution : $0 |
Lobbying on the following issues:
HEALTH ISSUES TAXATION/INTERNAL REVENUE CODE MEDICARE/MEDICAID Improving the performance of the health care system through better patient management and coordinated care, S 1895, health care oversight - HR 1398 and S 172, HR 3439, Health Insurance Tax Relief Act of 2019 - Medicare Advantage program improvements. Improvements in federal programs to provide better management and coordination of patient care and outcomes. S 1895 - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions Special Assistant to the Speaker for Policy Assistant to the President for Legislative Affairs Legislative Assistant Policy Analyst Assistant to the Speaker for Policy Special Assistant to the President for Legislative Affairs Policy Analyst Special Assistant to the President for Legislative Affairs Assistant to the Speaker for Policy Policy AnalystEgge, Sarah Kuehl Held the following Government positions Legislative Assistant, Sen. Bob Kerrey (1998-2000) Senior Budget Analyst, Senate Budget Committee (2001-2012) Deputy Staff Director, Joint Select Committee on Deficit Reduction (Fall 2011) Legislative Assistant to Sen. Bob Kerrey (1998-2000), Senior Budget Analyst to Senate Budget Committee (2001-2012), Deputy Staff Director to Joint Select Committee on Deficit Reduction (Fall 2011)
Foreign Entities: Foreign Entity Name : Fiat Chrysler Automobiles N.V.Country : UNITED KINGDOMContribution : $0 - Foreign Entity Name : FCA Holdco B.V.Country : UNITED KINGDOMContribution : $0 - Foreign Entity Name : FCA North American Holdings LLCCountry : USAContribution : $0 - |
Lobbying on the following issues:
MEDICARE/MEDICAID TAXATION/INTERNAL REVENUE CODE HEALTH ISSUES Medicare Advantage program improvements. Improvements in federal programs to provide better management and coordination of patient care and outcomes. - HR 1398 and S 172, Health Insurance Tax Relief Act of 2019 - Improving the performance of the health care system through better patient management and coordinated care. - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions Special Assistant to the Speaker for Policy Assistant to the President for Legislative Affairs Legislative Assistant Policy Analyst Assistant to the Speaker for Policy Special Assistant to the President for Legislative Affairs Policy Analyst Special Assistant to the President for Legislative Affairs Assistant to the Speaker for Policy Policy AnalystEgge, Sarah Kuehl Held the following Government positions Legislative Assistant, Sen. Bob Kerrey (1998-2000) Senior Budget Analyst, Senate Budget Committee (2001-2012) Deputy Staff Director, Joint Select Committee on Deficit Reduction (Fall 2011) Legislative Assistant to Sen. Bob Kerrey (1998-2000), Senior Budget Analyst to Senate Budget Committee (2001-2012), Deputy Staff Director to Joint Select Committee on Deficit Reduction (Fall 2011)
Foreign Entities: Foreign Entity Name: Samvardhana Motherson Group (SMG)Country : INDIAContribution : $30,000 |
Lobbying on the following issues:
HEALTH ISSUES TAXATION/INTERNAL REVENUE CODE MEDICARE/MEDICAID Improving the performance of the health care system through better patient management and coordinated care. - Repeal/delay of the health insurance tax. S 3063, S 1859, HR 4831, HR 4894 - Medicare Advantage program improvements. Improvements to federal programs to allow for prevention of addiction and improved management of opioid addiction. Improvements in federal programs to provide better management and coordination of patient care. - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions Special Assistant to the Speaker for Policy Assistant to the President for Legislative Affairs Legislative Assistant Policy Analyst Assistant to the Speaker for Policy Special Assistant to the President for Legislative Affairs Policy Analyst Special Assistant to the President for Legislative Affairs Assistant to the Speaker for Policy Policy AnalystEgge, Sarah Kuehl Held the following Government positions Legislative Assistant, Sen. Bob Kerrey (1998-2000) Senior Budget Analyst, Senate Budget Committee (2001-2012) Deputy Staff Director, Joint Select Committee on Deficit Reduction (Fall 2011) Legislative Assistant to Sen. Bob Kerrey (1998-2000), Senior Budget Analyst to Senate Budget Committee (2001-2012), Deputy Staff Director to Joint Select Committee on Deficit Reduction (Fall 2011)
|
Lobbying on the following issues:
MEDICARE/MEDICAID TAXATION/INTERNAL REVENUE CODE HEALTH ISSUES Medicare Advantage program improvements. Improvements in federal programs to provide better management and coordination of patient care and outcomes. S 1895 - HR 1398 and S 172, HR 3439, HR 1865 Health Insurance Tax Relief Act of 2019 - Improving the performance of the health care system through better patient management and coordinated care, S 1895 and HR 3630, reform for out of network bills, health care oversight - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions Special Assistant to the Speaker for Policy Assistant to the President for Legislative Affairs Legislative Assistant Policy Analyst Assistant to the Speaker for Policy Special Assistant to the President for Legislative Affairs Policy Analyst Special Assistant to the President for Legislative Affairs Assistant to the Speaker for Policy Policy AnalystEgge, Sarah Kuehl Held the following Government positions Legislative Assistant, Sen. Bob Kerrey (1998-2000) Senior Budget Analyst, Senate Budget Committee (2001-2012) Deputy Staff Director, Joint Select Committee on Deficit Reduction (Fall 2011) Legislative Assistant to Sen. Bob Kerrey (1998-2000), Senior Budget Analyst to Senate Budget Committee (2001-2012), Deputy Staff Director to Joint Select Committee on Deficit Reduction (Fall 2011)
|
Lobbying on the following issues:
MEDICARE/MEDICAID HR 2293/S 1223/HR 3429 To Exclude Complex Rehabilitative manual wheelchair accessories from the Medicare competitive acquisition program; Modify the Medicare coverage policy for power wheelchair standing and seat elevation; To provide for a separate benefit category for Complex Rehabilitation Technology in Medicare - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions Special Assistant to the President for Legislative Affairs Assistant to the Speaker for Policy Legislative Assistant Policy AnalystEgge, Sarah Kuehl Held the following Government positions Legislative Assistant Senior Budget Analyst Deputy Staff Director, Joint Select Committee on Deficit Reduction
|
Lobbying on the following issues:
MEDICARE/MEDICAID HR 2293/S 1223/HR 3429 To Exclude Complex Rehabilitative manual wheelchair accessories from the Medicare competitive acquisition program; Modify the Medicare coverage policy for power wheelchair standing and seat elevation; To provide for a separate benefit category for Complex Rehabilitation Technology in Medicare - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions Special Assistant to the President for Legislative Affairs Assistant to the Speaker for Policy Legislative Assistant Policy AnalystEgge, Sarah Kuehl Held the following Government positions Legislative Assistant Senior Budget Analyst Deputy Staff Director, Joint Select Committee on Deficit Reduction
|
Lobbying on the following issues:
MEDICARE/MEDICAID HR 2293/S 1223/HR 3429/HR 1865 To Exclude Complex Rehabilitative manual wheelchair accessories from the Medicare competitive acquisition program and make those policies permanent; Modify the Medicare coverage policy for power wheelchair standing and seat elevation; To provide for a separate benefit category for Complex Rehabilitation Technology in Medicare; Provide for telehealth coverage for CRT evaluation during the COVID19 pandemic. - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions Special Assistant to the President for Legislative Affairs Assistant to the Speaker for Policy Legislative Assistant Policy AnalystEgge, Sarah Kuehl Held the following Government positions Legislative Assistant Senior Budget Analyst Deputy Staff Director, Joint Select Committee on Deficit Reduction
Foreign Entities: Foreign Entity Name: Attestor Ltd.Country : UNITED KINGDOMContribution : $0 |
Lobbying on the following issues:
MEDICARE/MEDICAID HR 2293/S 1223/HR 3429/HR 1865 To Exclude Complex Rehabilitative manual wheelchair accessories from the Medicare competitive acquisition program; Modify the Medicare coverage policy for power wheelchair standing and seat elevation; To provide for a separate benefit category for Complex Rehabilitation Technology in Medicare - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions Special Assistant to the President for Legislative Affairs Assistant to the Speaker for Policy Legislative Assistant Policy AnalystEgge, Sarah Kuehl Held the following Government positions Legislative Assistant Senior Budget Analyst Deputy Staff Director, Joint Select Committee on Deficit Reduction
|
Lobbying on the following issues:
MEDICARE/MEDICAID HR 2293, To Exclude Complex Rehabilitative manual wheelchair accessories from the Medicare competitive acquisition program; Modify the Medicare coverage policy for power wheelchair standing and seat elevation; To provide for a separate benefit category for Complex Rehabilitation Technology in Medicare - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions Special Assistant to the President for Legislative Affairs Assistant to the Speaker for Policy Legislative Assistant Policy AnalystEgge, Sarah Kuehl Held the following Government positions Legislative Assistant Senior Budget Analyst Deputy Staff Director, Joint Select Committee on Deficit Reduction
Foreign Entities: Foreign Entity Name: Kalyani GroupCountry : INDIAContribution : $16,000 |
Lobbying on the following issues:
ALCOHOL AND DRUG ABUSE HEALTH ISSUES MEDICARE/MEDICAID Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings; Advance the use and funding of FDA-approved medicines to treat substance use disorder and alcohol use disorder in criminal justice and public health settings in the FY2021 appropriations for Labor-HHS, CJS and MilCon-VA bills - Awareness of the need for access to all FDA-approved medications for substance use disorder Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments for substance use disorder Initiatives to promote the use of relapse prevention post detoxification Advance the use and funding of FDA-approved medicines to treat serious mental illness in criminal justice and public health settings in the FY2021 appropriations for Labor-HHS and CJS bills - Maintain access to mental health medications for the low-income subsidy (LIS) eligible population under Medicare Part D in prescription drug reform legislation (S. 2543, Prescription Drug Pricing Reduction Act; H.R. 3, Lower Drug Costs Now Act) - Lobbyists: Egge, Sarah Kuehl Held the following Government positions 1998-2000 Legislative Assistant to Senator Bob Kerrey 2001-2012 Senior Budget Analyst for Senate Budget Committee (Kent Conrad) Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction
Foreign Entities: Foreign Entity Name : Russian Federation (38% ownership of Gazprom)Country : RUSSIAN FEDERATIONContribution : $0 - Foreign Entity Name : Public Joint Stock Company Gazprom (50% of NS2 operating budget)Country : RUSSIAN FEDERATIONContribution : $0 - |
Lobbying on the following issues:
HEALTH ISSUES Charitable premium assistance and end-stage renal disease issues; H.R. 1224/S. 511 Living Donor Protection Act; Advancing American Kidney Health Initiative (including Executive Order on Advancing American Kidney Health); Raising awareness around emergency needs arising from the COVID-19 pandemic in the low-income ESRD patient community - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions 1999-2001 Assistant to the Speaker for Policy 2003-2005 Special Assistant to the President for Special AffairsEgge, Sarah Kuehl Held the following Government positions 1998-2000 Legislative Assistant to Senator Bob Kerrey 2001-2012 Senior Budget Analyst for Senate Budget Committee (Kent Conrad) Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction
Foreign Entities: Foreign Entity Name : Russian Federation (38% ownership of Gazprom)Country : RUSSIAN FEDERATIONContribution : $0 - Foreign Entity Name : Public Joint Stock Company Gazprom (50% of NS2 operating budget)Country : RUSSIAN FEDERATIONContribution : $0 - |
Lobbying on the following issues:
MEDICARE/MEDICAID HEALTH ISSUES To ensure alternate payment methods are available in Medicaid reimbursement policy. - HR 2328 and S 192 and HR 1983, S 1895 To reauthorize and extend funding for Community Health Centers and the National Health Service Corps. - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions Special Assistant to the Speaker for Policy Assistant to the President for Policy Legislative Assistant Policy AnalystEgge, Sarah Kuehl Held the following Government positions Legislative Assistant, Sen. Bob Kerrey (1998-2000) Senior Budget Analyst, Senate Budget Committee (2001-2012) Deputy Staff Director, Joint Select Committee on Deficit Reduction (Fall 2011)
|
Lobbying on the following issues:
MEDICARE/MEDICAID HEALTH ISSUES To ensure alternate payment methods are available in Medicaid reimbursement policy. - HR 2328 and S 192 and HR 1983, S 1895 To reauthorize and extend funding for Community Health Centers and the National Health Service Corps. - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions Special Assistant to the Speaker for Policy Assistant to the President for Policy Legislative Assistant Policy AnalystEgge, Sarah Kuehl Held the following Government positions Legislative Assistant, Sen. Bob Kerrey (1998-2000) Senior Budget Analyst, Senate Budget Committee (2001-2012) Deputy Staff Director, Joint Select Committee on Deficit Reduction (Fall 2011)
Foreign Entities: Foreign Entity Name : Fiat Chrysler Automobiles N.V.Country : UNITED KINGDOMContribution : $0 - Foreign Entity Name : FCA Holdco B.V.Country : UNITED KINGDOMContribution : $0 - Foreign Entity Name : FCA North American Holdings LLCCountry : USAContribution : $0 - |
Lobbying on the following issues:
MEDICARE/MEDICAID Medicare Coverage and Reimbursement for Transformative Therapies - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions 1999-2001 Assistant to the Speaker for Policy 2003-2005 Special Assistant to the President for Special AffairsEgge, Sarah Kuehl Held the following Government positions 1998-2000 Legislative Assistant to Senator Bob Kerrey 2001-2012 Senior Budget Analyst for Senate Budget Committee (Senator Kent Conrad) Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction
Foreign Entities: Foreign Entity Name : LVMH Moet Hennessy Louis Vuitton SECountry : FRANCEContribution : $0 - Foreign Entity Name : Sofidiv S.A.S.Country : FRANCEContribution : $0 - |
Lobbying on the following issues:
MEDICARE/MEDICAID RNA interference scientific advancements; REFUND Act (S. 551/H.R. 4178) -- and REFUND Act provision in S. 2543, the Prescription Drug Pricing Reduction Act; CMS-1711-P (Medicare and Medicaid Programs; CY 2020 Home Health Prospective Payment System Rate Update; Home Health Value-Based Purchasing Model; Home Health Quality Reporting Requirements; and Home Infusion Therapy Requirements; Issues related to value-based arrangements) on proposed permanent rules for the new home infusion therapy benefit - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions 1999-2001 Assistant to the Speaker for Policy 2003-2005 Special Assistant to the President for Special AffairsEgge, Sarah Kuehl Held the following Government positions 1998-2000 Legislative Assistant to Senator Bob Kerrey 2001-2012 Senior Budget Analyst for Senate Budget Committee (Senator Kent Conrad) Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction
Foreign Entities: Foreign Entity Name: Inventys Thermal Technologies, Inc. dba Svante, Inc.Country : CANADAContribution : $45,000 |
Lobbying on the following issues:
MEDICARE/MEDICAID RNA interference scientific advancements; REFUND Act (S. 551/H.R. 4178) -- and REFUND Act provision in S. 2543, the Prescription Drug Pricing Reduction Act; CMS-1711-P (Medicare and Medicaid Programs; CY 2020 Home Health Prospective Payment System Rate Update; Home Health Value-Based Purchasing Model; Home Health Quality Reporting Requirements; and Home Infusion Therapy Requirements; Issues related to value-based arrangements) on proposed permanent rules for the new home infusion therapy benefit - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions 1999-2001 Assistant to the Speaker for Policy 2003-2005 Special Assistant to the President for Special AffairsEgge, Sarah Kuehl Held the following Government positions 1998-2000 Legislative Assistant to Senator Bob Kerrey 2001-2012 Senior Budget Analyst for Senate Budget Committee (Senator Kent Conrad) Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction
|
Lobbying on the following issues:
MEDICARE/MEDICAID Medicare Coverage and Reimbursement for Transformative Therapies - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions 1999-2001 Assistant to the Speaker for Policy 2003-2005 Special Assistant to the President for Special AffairsEgge, Sarah Kuehl Held the following Government positions 1998-2000 Legislative Assistant to Senator Bob Kerrey 2001-2012 Senior Budget Analyst for Senate Budget Committee (Senator Kent Conrad) Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction
Foreign Entities: Foreign Entity Name: Inventys Thermal Technologies, Inc. dba Svante, Inc.Country : CANADAContribution : $45,000 |
Lobbying on the following issues:
MEDICARE/MEDICAID RNA interference scientific advancements; REFUND Act (S. 551/H.R. 4178); CMS-1711-P (Medicare and Medicaid Programs; CY 2020 Home Health Prospective Payment System Rate Update; Home Health Value-Based Purchasing Model; Home Health Quality Reporting Requirements; and Home Infusion Therapy Requirements; Issues related to value-based arrangements) on proposed permanent rules for the new home infusion therapy benefit - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions 1999-2001 Assistant to the Speaker for Policy 2003-2005 Special Assistant to the President for Special AffairsEgge, Sarah Kuehl Held the following Government positions 1998-2000 Legislative Assistant to Senator Bob Kerrey 2001-2012 Senior Budget Analyst for Senate Budget Committee (Senator Kent Conrad) Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction
|
Lobbying on the following issues:
HEALTH ISSUES Charitable premium assistance and end-stage renal disease issues; H.R. 1224/S. 511 Living Donor Protection Act; Advancing American Kidney Health Initiative (including Executive Order on Advancing American Kidney Health) - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions 1999-2001 Assistant to the Speaker for Policy 2003-2005 Special Assistant to the President for Special AffairsEgge, Sarah Kuehl Held the following Government positions 1998-2000 Legislative Assistant to Senator Bob Kerrey 2001-2012 Senior Budget Analyst for Senate Budget Committee (Kent Conrad) Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction
|
Lobbying on the following issues:
MEDICARE/MEDICAID RNA interference scientific advancements; REFUND Act (S. 551/H.R. 4178) -- and REFUND Act provision in S. 2543, the Prescription Drug Pricing Reduction Act; expanding patient access to the Medicare home infusion benefit for drugs newly approved by the FDA after the establishment of the home infusion benefit -- CMS-1711-FC (Medicare and Medicaid Programs; CY 2020 Home Health Prospective Payment System Rate Update; Home Health Value-Based Purchasing Model; Home Health Quality Reporting Requirements; and Home Infusion Therapy Requirements; allowing for access to Part B infused drugs in the home setting for the duration of the COVID-19 public health emergency -- H.R. 748 CARES Act and CMS-1744-IFC Medicare and Medicaid Programs; Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions 1999-2001 Assistant to the Speaker for Policy 2003-2005 Special Assistant to the President for Special AffairsEgge, Sarah Kuehl Held the following Government positions 1998-2000 Legislative Assistant to Senator Bob Kerrey 2001-2012 Senior Budget Analyst for Senate Budget Committee (Senator Kent Conrad) Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction
Foreign Entities: Foreign Entity Name : Russian Federation (38% ownership of Gazprom)Country : RUSSIAN FEDERATIONContribution : $0 - Foreign Entity Name : Public Joint Stock Company Gazprom (50% of NS2 operating budget)Country : RUSSIAN FEDERATIONContribution : $0 - |
Lobbying on the following issues:
MEDICARE/MEDICAID Medicare Coverage and Reimbursement for Transformative Therapies - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions 1999-2001 Assistant to the Speaker for Policy 2003-2005 Special Assistant to the President for Special AffairsEgge, Sarah Kuehl Held the following Government positions 1998-2000 Legislative Assistant to Senator Bob Kerrey 2001-2012 Senior Budget Analyst for Senate Budget Committee (Senator Kent Conrad) Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction
Foreign Entities: Foreign Entity Name: Thai Union Group PCLCountry : THAILANDContribution : $15,000 |
Lobbying on the following issues:
MEDICARE/MEDICAID HEALTH ISSUES ALCOHOL AND DRUG ABUSE Maintain access to mental health medications for the low-income subsidy (LIS) eligible population under Medicare Part D in prescription drug reform legislation (S. 2543, Prescription Drug Pricing Reduction Act; H.R. 3, Lower Drug Costs Now Act) - Awareness of the need for access to all FDA-approved medications Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments Initiatives to promote the use of relapse prevention post detoxification - Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings; FY2020 appropriations for Labor-HHS, CJS and Interior (Indian Health Service) bills; CREATE Opportunities Act (S. 1983/H.R. 3496) - Lobbyists: Egge, Sarah Kuehl Held the following Government positions 1998-2000 Legislative Assistant to Senator Bob Kerrey 2001-2012 Senior Budget Analyst for Senate Budget Committee (Kent Conrad) Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction
Foreign Entities: Foreign Entity Name: Thai Union Group PCLCountry : THAILANDContribution : $15,000 |
Lobbying on the following issues:
ALCOHOL AND DRUG ABUSE HEALTH ISSUES MEDICARE/MEDICAID Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings; FY2020 appropriations for Labor-HHS, CJS and Interior (Indian Health Service) bills - Awareness of the need for access to all FDA-approved medications Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments Initiatives to promote the use of relapse prevention post detoxification - Maintain access to mental health medications for the low-income subsidy (LIS) eligible population under Medicare Part D in prescription drug reform legislation (S. 2543, Prescription Drug Pricing Reduction Act; H.R. 3, Lower Drug Costs Now Act) - Lobbyists: Egge, Sarah Kuehl Held the following Government positions 1998-2000 Legislative Assistant to Senator Bob Kerrey 2001-2012 Senior Budget Analyst for Senate Budget Committee (Kent Conrad) Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction
Foreign Entities: Foreign Entity Name : Zhanneta Levievna IsakovaCountry : RUSSIAN FEDERATIONContribution : $0 - Foreign Entity Name : Andrey Vladislavovich TokarevCountry : RUSSIAN FEDERATIONContribution : $0 - |
Lobbying on the following issues:
HEALTH ISSUES Charitable premium assistance and end-stage renal disease issues; H.R. 1224/S. 511 Living Donor Protection Act; Advancing American Kidney Health Initiative (including Executive Order on Advancing American Kidney Health) - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions 1999-2001 Assistant to the Speaker for Policy 2003-2005 Special Assistant to the President for Special AffairsEgge, Sarah Kuehl Held the following Government positions 1998-2000 Legislative Assistant to Senator Bob Kerrey 2001-2012 Senior Budget Analyst for Senate Budget Committee (Kent Conrad) Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction
Foreign Entities: Foreign Entity Name: Inventys Thermal Technologies, Inc. dba Svante, Inc.Country : CANADAContribution : $45,000 |
Lobbying on the following issues:
MEDICARE/MEDICAID HEALTH ISSUES Medicare Coverage and Reimbursement for Transformative Therapies - S. 340/H.R. 965 CREATES Act - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions 1999-2001 Assistant to the Speaker for Policy 2003-2005 Special Assistant to the President for Special Affairs 1999-2001 Assistant to the Speaker for Policy 2003-2005 Special Assistant to the President for Special AffairsEgge, Sarah Kuehl Held the following Government positions 1998-2000 Legislative Assistant to Senator Bob Kerrey 2001-2012 Senior Budget Analyst for Senate Budget Committee (Kent Conrad) Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction 1998-2000 Legislative Assistant to Senator Bob Kerrey 2001-2012 Senior Budget Analyst for Senate Budget Committee (Senator Kent Conrad) Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction
Foreign Entities: Foreign Entity Name: Swiss Reinsurance Company LtdCountry : SWITZERLANDContribution : $0 |
Lobbying on the following issues:
ALCOHOL AND DRUG ABUSE H.R. 5327/S. 2589 Comprehensive Opioid Recovery Centers Act of 2018; S. 2680, The Opioid Crisis Response Act of 2018; H.R 6, SUPPORT for Patients and Communities Act; S.3158, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019; S.3072, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2019. - Lobbyists: Egge, Sarah Kuehl Held the following Government positions 1998-2000 Legislative Assistant to Senator Bob Kerrey 2001-2012 Senior Budget Analyst for Senate Budget Committee (Kent Conrad) Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction
Foreign Entities: Foreign Entity Name: Aon, plcCountry : UNITED KINGDOMContribution : $0 |
Lobbying on the following issues:
HEALTH ISSUES Extend funding for Community Health Centers- HR 3770, HR 6-funding for Community Health Centers opioid use prevention and treatment services, Implementation of state value-based payment models - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions Special Assistant to the Speaker for Policy Assistant to the President for Policy Legislative Assistant Policy AnalystEgge, Sarah Kuehl Held the following Government positions Legislative Assistant, Sen. Bob Kerrey (1998-2000) Senior Budget Analyst, Senate Budget Committee (2001-2012) Deputy Staff Director, Joint Select Committee on Deficit Reduction (Fall 2011)
|
Lobbying on the following issues:
HEALTH ISSUES Charitable premium assistance and end-stage renal disease issues; H.R.3976 - Access to Marketplace Insurance Act - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions 1999-2001 Assistant to the Speaker for Policy 2003-2005 Special Assistant to the President for Special AffairsEgge, Sarah Kuehl Held the following Government positions 1998-2000 Legislative Assistant to Senator Bob Kerrey 2001-2012 Senior Budget Analyst for Senate Budget Committee (Kent Conrad) Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction
Foreign Entities: Foreign Entity Name: Aon, plcCountry : UNITED KINGDOMContribution : $0 |
Lobbying on the following issues:
MEDICARE/MEDICAID HEALTH ISSUES To ensure alternate payment methods are available in Medicaid reimbursement policy. Reimbursement for Telehealth services - HR 2328 and S 192 and HR 1983, S 1895 To reauthorize and extend funding for Community Health Centers and the National Health Service Corps. HR 748 CARES Act, HR 6074 Coronavirus Preparedness and Response Act, HR 6201 Families First Coronavirus Response Act. Reimbursement for telehealth services. - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions Special Assistant to the Speaker for Policy Assistant to the President for Policy Legislative Assistant Policy AnalystEgge, Sarah Kuehl Held the following Government positions Legislative Assistant, Sen. Bob Kerrey (1998-2000) Senior Budget Analyst, Senate Budget Committee (2001-2012) Deputy Staff Director, Joint Select Committee on Deficit Reduction (Fall 2011)
Foreign Entities: Foreign Entity Name: Attestor Ltd.Country : UNITED KINGDOMContribution : $0 |
Lobbying on the following issues:
MEDICARE/MEDICAID HEALTH ISSUES To ensure alternate payment methods are available in Medicaid reimbursement policy. - HR 2328 and S 192 and HR 1983, To reauthorize and extend funding for Community Health Centers and the National Health Service Corps. - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions Special Assistant to the Speaker for Policy Assistant to the President for Policy Legislative Assistant Policy AnalystEgge, Sarah Kuehl Held the following Government positions Legislative Assistant, Sen. Bob Kerrey (1998-2000) Senior Budget Analyst, Senate Budget Committee (2001-2012) Deputy Staff Director, Joint Select Committee on Deficit Reduction (Fall 2011)
Foreign Entities: Foreign Entity Name: Samvardhana Motherson Group (SMG)Country : INDIAContribution : $30,000 |
Lobbying on the following issues:
HEALTH ISSUES HR 2212/S 974 - CREATES Act; HR 2051 - FAST Generics Act; Medicare Coverage and Reimbursement for Transformative Therapies - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions 1999-2001 Assistant to the Speaker for Policy 2003-2005 Special Assistant to the President for Special AffairsEgge, Sarah Kuehl Held the following Government positions 1998-2000 Legislative Assistant to Senator Bob Kerrey 2001-2012 Senior Budget Analyst for Senate Budget Committee (Kent Conrad) Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction
Foreign Entities: Foreign Entity Name: Aon, plcCountry : UNITED KINGDOMContribution : $0 |
Lobbying on the following issues:
HEALTH ISSUES ALCOHOL AND DRUG ABUSE MEDICARE/MEDICAID Awareness of the need for access to all FDA-approved medications Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments Initiatives to promote the use of relapse prevention post detoxification - Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings; FY2020 appropriations for Labor-HHS, CJS and Interior (Indian Health Service) bills - Maintain six protected classes for depression and schizophrenia under Medicare Part D - Lobbyists: Egge, Sarah Kuehl Held the following Government positions 1998-2000 Legislative Assistant to Senator Bob Kerrey 2001-2012 Senior Budget Analyst for Senate Budget Committee (Kent Conrad) Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction
Foreign Entities: Foreign Entity Name : Roivant Sciences Holdings Ltd.Country : UNITED KINGDOMContribution : $0 - Foreign Entity Name : Roivant Sciences Ltd.Country : BERMUDAContribution : $0 - |
Lobbying on the following issues:
HEALTH ISSUES Charitable premium assistance and end-stage renal disease issues; H.R. 1224/S. 511 Living Donor Protection Act - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions 1999-2001 Assistant to the Speaker for Policy 2003-2005 Special Assistant to the President for Special AffairsEgge, Sarah Kuehl Held the following Government positions 1998-2000 Legislative Assistant to Senator Bob Kerrey 2001-2012 Senior Budget Analyst for Senate Budget Committee (Kent Conrad) Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction
Foreign Entities: Foreign Entity Name: Swiss Reinsurance Company LtdCountry : SWITZERLANDContribution : $0 |
Lobbying on the following issues:
MEDICARE/MEDICAID RNA interference scientific advancements; CMS-1689-F -- 2019 Home Health/Home Infusion Therapy final rule; Issues related to value-based arrangements - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions 1999-2001 Assistant to the Speaker for Policy 2003-2005 Special Assistant to the President for Special AffairsEgge, Sarah Kuehl Held the following Government positions 1998-2000 Legislative Assistant to Senator Bob Kerrey 2001-2012 Senior Budget Analyst for Senate Budget Committee (Senator Kent Conrad) Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction
Foreign Entities: Foreign Entity Name: Swiss Reinsurance Company LtdCountry : SWITZERLANDContribution : $0 |
Lobbying on the following issues:
MEDICARE/MEDICAID Medicare Coverage and Reimbursement for Transformative Therapies - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions 1999-2001 Assistant to the Speaker for Policy 2003-2005 Special Assistant to the President for Special AffairsEgge, Sarah Kuehl Held the following Government positions 1998-2000 Legislative Assistant to Senator Bob Kerrey 2001-2012 Senior Budget Analyst for Senate Budget Committee (Senator Kent Conrad) Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction
Foreign Entities: Foreign Entity Name : Philip Morris Brands Sarl (Parent company is PMI)Country : SWITZERLANDContribution : $0 - Foreign Entity Name : Philip Morris Products S.A. (Parent company is PMI)Country : SWITZERLANDContribution : $0 - Foreign Entity Name : PMI Management, SA (Parent Co. is PMI)Country : |
Lobbying on the following issues:
MEDICARE/MEDICAID HEALTH ISSUES ALCOHOL AND DRUG ABUSE Maintain six protected classes for depression and schizophrenia under Medicare Part D - Awareness of the need for access to all FDA-approved medications Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments Initiatives to promote the use of relapse prevention post detoxification - Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings; FY2020 appropriations for Labor-HHS, CJS and Interior (Indian Health Service) bills; CREATE Opportunities Act (S. 1983/H.R. 3496) - Lobbyists: Egge, Sarah Kuehl Held the following Government positions 1998-2000 Legislative Assistant to Senator Bob Kerrey 2001-2012 Senior Budget Analyst for Senate Budget Committee (Kent Conrad) Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction
Foreign Entities: Foreign Entity Name : Philip Morris Brands Sarl (Parent company is PMI)Country : SWITZERLANDContribution : $0 - Foreign Entity Name : Philip Morris Products S.A. (Parent company is PMI)Country : SWITZERLANDContribution : $0 - Foreign Entity Name : PMI Management, SA (Parent Co. is PMI)Country : |
Lobbying on the following issues:
MEDICARE/MEDICAID RNA interference scientific advancements; REFUND Act (S. 551); CMS-1689-F -- 2019 Home Health/Home Infusion Therapy final rule; Issues related to value-based arrangements - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions 1999-2001 Assistant to the Speaker for Policy 2003-2005 Special Assistant to the President for Special AffairsEgge, Sarah Kuehl Held the following Government positions 1998-2000 Legislative Assistant to Senator Bob Kerrey 2001-2012 Senior Budget Analyst for Senate Budget Committee (Senator Kent Conrad) Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction
Foreign Entities: Foreign Entity Name : Philip Morris Brands Sarl (Parent company is PMI)Country : SWITZERLANDContribution : $0 - Foreign Entity Name : Philip Morris Products S.A. (Parent company is PMI)Country : SWITZERLANDContribution : $0 - Foreign Entity Name : PMI Management, SA (Parent Co. is PMI)Country : |
Lobbying on the following issues:
HEALTH ISSUES Charitable premium assistance and end-stage renal disease issues; H.R. 1224/S. 511 Living Donor Protection Act; Advancing American Kidney Health Initiative - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions 1999-2001 Assistant to the Speaker for Policy 2003-2005 Special Assistant to the President for Special AffairsEgge, Sarah Kuehl Held the following Government positions 1998-2000 Legislative Assistant to Senator Bob Kerrey 2001-2012 Senior Budget Analyst for Senate Budget Committee (Kent Conrad) Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction
Foreign Entities: Foreign Entity Name : Philip Morris Brands Sarl (Parent company is PMI)Country : SWITZERLANDContribution : $0 - Foreign Entity Name : Philip Morris Products S.A. (Parent company is PMI)Country : SWITZERLANDContribution : $0 - Foreign Entity Name : PMI Management, SA (Parent Co. is PMI)Country : |
Lobbying on the following issues:
MEDICARE/MEDICAID Medicare Reimbursement for Transformative Therapies - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions 1999-2001 Assistant to the Speaker for Policy 2003-2005 Special Assistant to the President for Special AffairsEgge, Sarah Kuehl Held the following Government positions 1998-2000 Legislative Assistant to Senator Bob Kerrey 2001-2012 Senior Budget Analyst for Senate Budget Committee (Senator Kent Conrad) Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction
Foreign Entities: Foreign Entity Name: DO & CO AktiengesellschaftCountry : AUSTRIAContribution : $0 |
Lobbying on the following issues:
HEALTH ISSUES MEDICARE/MEDICAID HR 2328 and S 192 and HR 1983, S 1895, To reauthorize and extend funding for Community Health Centers and the National Health Service Corps. - To ensure alternate payment methods are available in Medicaid reimbursement policy. - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions Special Assistant to the Speaker for Policy Assistant to the President for Policy Legislative Assistant Policy AnalystEgge, Sarah Kuehl Held the following Government positions Legislative Assistant, Sen. Bob Kerrey (1998-2000) Senior Budget Analyst, Senate Budget Committee (2001-2012) Deputy Staff Director, Joint Select Committee on Deficit Reduction (Fall 2011)
Foreign Entities: Foreign Entity Name : Roivant Sciences Holdings Ltd.Country : UNITED KINGDOMContribution : $0 - Foreign Entity Name : Roivant Sciences Ltd.Country : BERMUDAContribution : $0 - |
Lobbying on the following issues:
MEDICARE/MEDICAID HEALTH ISSUES COPYRIGHT/PATENT/TRADEMARK MEDICAL/DISEASE RESEARCH/CLINICAL LABS Medicare coverage and reimbursement of Next Generation Sequencing and other advanced diagnostic testing for advanced cancers. PAMA reform of clinical laboratory reimbursement. - VALID Act, discussion draft to provide Food & Drug Administration oversight of diagnostic laboratory testing. - Tillis/Coons draft to strengthen patent protections for cancer diagnostic tests - FDA oversight of Next Generation Sequencing technology for advanced cancers. Medicare coverage of Next Generation Sequencing technology for advanced cancers. PAMA reform of Medicare clinical laboratory payments. VALID Act to provide FDA oversight of clinical laboratory testing. Section 8122 of SUPPORT for Patients and Communities Act to address application to cancer laboratories - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions Special Assistant to the President for Legislative Affairs Assistant to the Speaker for Policy Legislative Assistant Policy Analyst Special Assistant to the Speaker for Policy Special Assistant to the President for Legislative Affairs Policy Analyst
Foreign Entities: Foreign Entity Name : Roivant Sciences Holdings Ltd.Country : UNITED KINGDOMContribution : $0 - Foreign Entity Name : Roivant Sciences Ltd.Country : BERMUDAContribution : $0 - |
Lobbying on the following issues:
HEALTH ISSUES MEDICARE/MEDICAID MEDICAL/DISEASE RESEARCH/CLINICAL LABS COPYRIGHT/PATENT/TRADEMARK VALID Act, discussion draft to provide Food & Drug Administration oversight of diagnostic laboratory testing. - Medicare coverage and reimbursement of Next Generation Sequencing and other advanced diagnostic testing for advanced cancers. PAMA reform of clinical laboratory reimbursement. - FDA oversight of Next Generation Sequencing technology for advanced cancers. Medicare coverage of Next Generation Sequencing technology for advanced cancers. PAMA reform of Medicare clinical laboratory payments. VALID Act to provide FDA oversight of clinical laboratory testing. Section 8122 of SUPPORT for Patients and Communities Act to address application to cancer laboratories - Tillis/Coons draft to strengthen patent protections for cancer diagnostic tests - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions Special Assistant to the President for Legislative Affairs Assistant to the Speaker for Policy Legislative Assistant Policy Analyst Special Assistant to the Speaker for Policy Special Assistant to the President for Legislative Affairs Policy AnalystEgge, Sarah Kuehl Held the following Government positions Legislative Assistant Senior Budget Analyst Deputy Staff Director, Joint Select Committee on Deficit Reduction
|
Lobbying on the following issues:
COPYRIGHT/PATENT/TRADEMARK MEDICARE/MEDICAID MEDICAL/DISEASE RESEARCH/CLINICAL LABS HEALTH ISSUES Policy concepts to strengthen patent protections for cancer diagnostic tests - Medicare coverage and reimbursement of Next Generation Sequencing and other advanced diagnostic testing for advanced cancers. - FDA oversight of Next Generation Sequencing technology for advanced cancers. Medicare coverage of Next Generation Sequencing technology for advanced cancers. VALID Act to provide FDA oversight of clinical laboratory testing. Section 8122 of SUPPORT for Patients and Communities Act to address application to cancer laboratories - VALID Act, discussion draft to provide Food & Drug Administration oversight of diagnostic laboratory testing. - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions Special Assistant to the President for Legislative Affairs Assistant to the Speaker for Policy Legislative Assistant Policy Analyst Special Assistant to the Speaker for Policy Special Assistant to the President for Legislative Affairs Policy AnalystEgge, Sarah Kuehl Held the following Government positions Legislative Assistant Senior Budget Analyst Deputy Staff Director, Joint Select Committee on Deficit Reduction
Foreign Entities: Foreign Entity Name: Attestor Ltd.Country : UNITED KINGDOMContribution : $0 |
Lobbying on the following issues:
MEDICARE/MEDICAID MEDICAL/DISEASE RESEARCH/CLINICAL LABS HEALTH ISSUES Medicare coverage and reimbursement of Next Generation Sequencing and other advanced diagnostic testing for advanced cancers. PAMA reform of clinical laboratory reimbursement. - FDA oversight of Next Generation Sequencing technology for advanced cancers. Medicare coverage of Next Generation Sequencing technology for advanced cancers. PAMA reform of Medicare clinical laboratory payments. VALID Act to provide FDA oversight of clinical laboratory testing. - VALID Act, discussion draft to provide Food & Drug Administration oversight of diagnostic laboratory testing. - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions Special Assistant to the President for Legislative Affairs Assistant to the Speaker for Policy Legislative Assistant Policy Analyst
Foreign Entities: Foreign Entity Name: Bayer AGCountry : GERMANYContribution : $0 |
Lobbying on the following issues:
COPYRIGHT/PATENT/TRADEMARK MEDICAL/DISEASE RESEARCH/CLINICAL LABS MEDICARE/MEDICAID HEALTH ISSUES Tillis/Coons draft to strengthen patent protections for cancer diagnostic tests - FDA oversight of Next Generation Sequencing technology for advanced cancers. Medicare coverage of Next Generation Sequencing technology for advanced cancers. PAMA reform of Medicare clinical laboratory payments. VALID Act to provide FDA oversight of clinical laboratory testing. Section 8122 of SUPPORT for Patients and Communities Act to address application to cancer laboratories - Medicare coverage and reimbursement of Next Generation Sequencing and other advanced diagnostic testing for advanced cancers. PAMA reform of clinical laboratory reimbursement. - VALID Act, discussion draft to provide Food & Drug Administration oversight of diagnostic laboratory testing. - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions Special Assistant to the President for Legislative Affairs Assistant to the Speaker for Policy Legislative Assistant Policy Analyst Special Assistant to the Speaker for Policy Special Assistant to the President for Legislative Affairs Policy AnalystEgge, Sarah Kuehl Held the following Government positions Legislative Assistant Senior Budget Analyst Deputy Staff Director, Joint Select Committee on Deficit Reduction
Foreign Entities: Foreign Entity Name : Fiat Chrysler Automobiles N.V.Country : UNITED KINGDOMContribution : $0 - Foreign Entity Name : FCA Holdco B.V.Country : UNITED KINGDOMContribution : $0 - Foreign Entity Name : FCA North American Holdings LLCCountry : USAContribution : $0 - |
Lobbying on the following issues:
HEALTH ISSUES MEDICARE/MEDICAID S. 1895, Lower Health Care Costs Act; HR 1865; MACRA implementation - Improvements to Medicare Advantage to ensure more beneficiaries benefit from the program, Strengthening Accountable Care Organizations - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions 1999-2001 Assistant to the Speaker for Policy 2003-2005 Special Assistant to the President for Special Affairs Special Assistant to the President for Legislative Affairs Assistant to the Speaker for Policy Legislative Assistant Policy AnalystEgge, Sarah Kuehl Held the following Government positions Legislative Assistant Senior Budget Analyst Deputy Staff Director, Joint Select Committee on Deficit Reduction Legislative Assistant Deputy Staff Director, Joint Select Committee on Deficit Reduction
|
Lobbying on the following issues:
HEALTH ISSUES MEDICARE/MEDICAID S. 1895, Lower Health Care Costs Act; HR 1865; MACRA implementation. HR 748 CARES Act, HR 6074 Coronavirus Preparedness and Response Act, HR 6201 Families First Coronavirus Response Act. - Improvements to Medicare Advantage to ensure more beneficiaries benefit from the program, strengthening Accountable Care Organizations, improving value-based payment models. - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions 1999-2001 Assistant to the Speaker for Policy 2003-2005 Special Assistant to the President for Special Affairs Special Assistant to the President for Legislative Affairs Assistant to the Speaker for Policy Legislative Assistant Policy AnalystEgge, Sarah Kuehl Held the following Government positions Legislative Assistant Senior Budget Analyst Deputy Staff Director, Joint Select Committee on Deficit Reduction Legislative Assistant Deputy Staff Director, Joint Select Committee on Deficit Reduction
Foreign Entities: Foreign Entity Name: Attestor Ltd.Country : UNITED KINGDOMContribution : $0 |
Lobbying on the following issues:
HEALTH ISSUES RNA interference scientific advancements; CMS-1689-P -- 2019 Home Health/Home Infusion Therapy proposed rule - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions 1999-2001 Assistant to the Speaker for Policy 2003-2005 Special Assistant to the President for Special AffairsEgge, Sarah Kuehl Held the following Government positions ​1998-2000 Legislative Assistant to Senator Bob Kerrey 2001-2012 Senior Budget Analyst for Senate Budget Committee (Kent Conrad) Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction
Foreign Entities: Foreign Entity Name: Aon, plcCountry : UNITED KINGDOMContribution : $0 |
Lobbying on the following issues:
MEDICARE/MEDICAID HEALTH ISSUES Improvements to Medicare Advantage to ensure more beneficiaries benefit from the program - S. 1895, Lower Health Care Costs Act; MACRA implementation - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions 1999-2001 Assistant to the Speaker for Policy 2003-2005 Special Assistant to the President for Special Affairs Special Assistant to the President for Legislative Affairs Assistant to the Speaker for Policy Legislative Assistant Policy AnalystEgge, Sarah Kuehl Held the following Government positions Legislative Assistant Senior Budget Analyst Deputy Staff Director, Joint Select Committee on Deficit Reduction Legislative Assistant Deputy Staff Director, Joint Select Committee on Deficit Reduction
Foreign Entities: Foreign Entity Name : Fiat Chrysler Automobiles N.V.Country : UNITED KINGDOMContribution : $0 - Foreign Entity Name : FCA North America Holdings, LLCCountry : USAContribution : $0 - Foreign Entity Name : FCA Holdco B.V.Country : UNITED KINGDOMContribution : $0 - |
Lobbying on the following issues:
MEDICARE/MEDICAID HR 7217 the IMPROVE Act, S 486, HR 750, HR 4229, CMS-1687-IFC Durable Medical Equipment Fee Schedule adjustments, Implementation of Medicaid cuts for Durable Medical Equipment in the 21st Century Cures law to protect Complex Rehabilitation Technology (CRT), CMS proposed CY2019 proposed rule (CMS-1691-P) to protect access for patients with severe disabilities. - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions Special Assistant to the President for Legislative Affairs Assistant to the Speaker for Policy Legislative Assistant Policy AnalystEgge, Sarah Kuehl Held the following Government positions Legislative Assistant Senior Budget Analyst Deputy Staff Director, Joint Select Committee on Deficit Reduction
|
Lobbying on the following issues:
HEALTH ISSUES MEDICARE/MEDICAID General health care issues related to rural health care; reauthorization of the Patient-Centered Outcomes Research Institute (PCORI) (H.R. 3439, S. 2897). - General rural health care issues, including Medicare reimbursement reforms. - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions 1999-2001 Assistant to the Speaker for Policy 2003-2005 Special Assistant to the President for Legislative Affairs 1999-2001 Assistant to the Speaker for Policy 2003-2005 Special Assistant to the President for Special AffairsEgge, Sarah Kuehl Held the following Government positions 1998-2000 Legislative Assistant to Senator Bob Kerrey 2001-2012 Senior Budget Analyst for Senate Budget Committee (Kent Conrad) Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction 1998-2000 Legislative Assistant to Senator Bob Kerrey 2001-2012 Senior Budget Analyst for Senate Budget Committee (Senator Kent Conrad) Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction
|
Lobbying on the following issues:
HEALTH ISSUES General health care issues related to rural health care, reauthorization of the Patient-Centered Outcomes Research Institute (PCORI), and efforts to address the opioid epidemic. - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions 1999-2001 Assistant to the Speaker for Policy 2003-2005 Special Assistant to the President for Legislative AffairsEgge, Sarah Kuehl Held the following Government positions 1998-2000 Legislative Assistant to Senator Bob Kerrey 2001-2012 Senior Budget Analyst for Senate Budget Committee (Kent Conrad) Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction
Foreign Entities: Foreign Entity Name: Thai Union Group PCLCountry : THAILANDContribution : $15,000 |
Lobbying on the following issues:
MEDICARE/MEDICAID HEALTH ISSUES General rural health care issues, including Medicare reimbursement reforms. - General health care issues related to improving patient access and stability for rural health care providers; bipartisan approaches to improving health care in the U.S., public health response related to COVID-19 pandemic (H.R. 6074: Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; H.R. 6201: Families First Coronavirus Response Act; H.R. 748 CARES Act) - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions 1999-2001 Assistant to the Speaker for Policy 2003-2005 Special Assistant to the President for Legislative Affairs 1999-2001 Assistant to the Speaker for Policy 2003-2005 Special Assistant to the President for Special AffairsEgge, Sarah Kuehl Held the following Government positions 1998-2000 Legislative Assistant to Senator Bob Kerrey 2001-2012 Senior Budget Analyst for Senate Budget Committee (Kent Conrad) Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction 1998-2000 Legislative Assistant to Senator Bob Kerrey 2001-2012 Senior Budget Analyst for Senate Budget Committee (Senator Kent Conrad) Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction
Foreign Entities: Foreign Entity Name : Russian Federation (38% ownership of Gazprom)Country : RUSSIAN FEDERATIONContribution : $0 - Foreign Entity Name : Public Joint Stock Company Gazprom (50% of NS2 operating budget)Country : RUSSIAN FEDERATIONContribution : $0 - |
Lobbying on the following issues:
HEALTH ISSUES General health care issues related to insurance markets, long-term care, chronic care, rural health care, reauthorization of the Patient-Centered Outcomes Research Institute (PCORI) and efforts to address the opioid epidemic (including implementation of FY17 and FY18 federal funding to address the opioid epidemic). - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions 1999-2001 Assistant to the Speaker for Policy 2003-2005 Special Assistant to the President for Legislative AffairsEgge, Sarah Kuehl Held the following Government positions 1998-2000 Legislative Assistant to Senator Bob Kerrey 2001-2012 Senior Budget Analyst for Senate Budget Committee (Kent Conrad) Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction
Foreign Entities: Foreign Entity Name : Philip Morris Brands Sarl (Parent company is PMI)Country : SWITZERLANDContribution : $0 - Foreign Entity Name : Philip Morris Products S.A. (Parent company is PMI)Country : SWITZERLANDContribution : $0 - Foreign Entity Name : PMI Management, SA (Parent Co. is PMI)Country : |
Lobbying on the following issues:
HEALTH ISSUES General health care issues related to insurance markets, long-term care, chronic care, rural health care, reauthorization of the Patient-Centered Outcomes Research Institute and efforts to address the opioid epidemic (including implementation of FY17 and FY18 federal funding to address the opioid epidemic). - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions 1999-2001 Assistant to the Speaker for Policy 2003-2005 Special Assistant to the President for Legislative AffairsEgge, Sarah Kuehl Held the following Government positions 1998-2000 Legislative Assistant to Senator Bob Kerrey 2001-2012 Senior Budget Analyst for Senate Budget Committee (Kent Conrad) Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction
Foreign Entities: Foreign Entity Name: Swiss Reinsurance Company LtdCountry : SWITZERLANDContribution : $0 |
Lobbying on the following issues:
MEDICAL/DISEASE RESEARCH/CLINICAL LABS HEALTH ISSUES MEDICARE/MEDICAID FDA oversight of Next Generation Sequencing technology for advanced cancers. Medicare coverage of Next Generation Sequencing technology for advanced cancers. PAMA reform of Medicare clinical lab payments. - Discussion draft by Reps. Bucshon and DeGette to reform the Food & Drug Administration's oversight of diagnostic medical devices and clinical lab services. - Medicare coverage and reimbursement of Next Generation Sequencing in advanced cancer. PAMA reform of clinical lab reimbursement - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions Special Assistant to the President for Legislative Affairs Assistant to the Speaker for Policy Legislative Assistant Policy Analyst
|
Lobbying on the following issues:
HEALTH ISSUES BUDGET/APPROPRIATIONS General health care issues related to insurance markets, long-term care, chronic care, rural health care and efforts to address the opioid epidemic - General budget process reform issues and issues in relation to the Joint Select Committee on Budget and Appropriations Process Reform - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions 1999-2001 Assistant to the Speaker for Policy 2003-2005 Special Assistant to the President for Legislative Affairs 1999-2001 Assistant to the Speaker for Policy 2003-2005 Special Assistant to the President for Legislative AffairsEgge, Sarah Kuehl Held the following Government positions 1998-2000 Legislative Assistant to Senator Bob Kerrey 2001-2012 Senior Budget Analyst for Senate Budget Committee (Kent Conrad) Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction 1998-2000 Legislative Assistant to Senator Bob Kerrey Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction
Foreign Entities: Foreign Entity Name: Aon, plcCountry : UNITED KINGDOMContribution : $0 |
Lobbying on the following issues:
HEALTH ISSUES S. 1895, Lower Health Care Costs Act; MACRA implementation - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions 1999-2001 Assistant to the Speaker for Policy 2003-2005 Special Assistant to the President for Special Affairs
|
Lobbying on the following issues:
MEDICARE/MEDICAID Medicare Coverage and Reimbursement for Transformative Therapies - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions 1999-2001 Assistant to the Speaker for Policy 2003-2005 Special Assistant to the President for Special AffairsEgge, Sarah Kuehl Held the following Government positions 1998-2000 Legislative Assistant to Senator Bob Kerrey 2001-2012 Senior Budget Analyst for Senate Budget Committee (Senator Kent Conrad) Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction
Foreign Entities: Foreign Entity Name: AES-3C Maritza EastCountry : BULGARIAContribution : $3,953 |
Lobbying on the following issues:
HEALTH ISSUES MEDICARE/MEDICAID Medicare Advantage, physician reimbursement, delivery system reform, and alternative payment model issues - Lobbyists: JENSEN CUNNIFFE, AMY Held the following Government positions 1999-2001 Assistant to the Speaker for Policy 2003-2005 Special Assistant to the President for Special AffairsEgge, Sarah Kuehl Held the following Government positions 1998-2000 Legislative Assistant to Senator Bob Kerrey 2001-2012 Senior Budget Analyst for Senate Budget Committee (Senator Kent Conrad) Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction
Foreign Entities: Foreign Entity Name: Wright Medical Group, N.V.Country : NETHERLANDSContribution : $0 |
Money Spent:
Amount | Client | Government Entities |
---|
$80,000
Apr 22, 2019
FIRST QUARTER AMENDMENT
UnitedHealth Group
UHG enhances the performance of the health system and improves the health of those served.
HOUSE OF REPRESENTATIVESSENATE
$80,000
Jul 22, 2019
SECOND QUARTER REPORT
UnitedHealth Group
UHG enhances the performance of the health system and improves the health of those served.
HOUSE OF REPRESENTATIVESSENATE
$80,000
Apr 17, 2020
FIRST QUARTER REPORT
UnitedHealth Group
UHG enhances the performance of the health system and improves the health of those served.
HOUSE OF REPRESENTATIVESSENATE
$80,000
Oct 21, 2019
THIRD QUARTER REPORT
UnitedHealth Group
UHG enhances the performance of the health system and improves the health of those served.
HOUSE OF REPRESENTATIVESSENATE
$80,000
Apr 22, 2019
FIRST QUARTER REPORT
UnitedHealth Group
UHG enhances the performance of the health system and improves the health of those served.
HOUSE OF REPRESENTATIVESSENATE
$80,000
Jan 21, 2019
FOURTH QUARTER REPORT
UnitedHealth Group
UHG enhances the performance of the health system and improves the health of those served.
HOUSE OF REPRESENTATIVESSENATE
$80,000
Jan 19, 2020
FOURTH QUARTER REPORT
UnitedHealth Group
UHG enhances the performance of the health system and improves the health of those served.
HOUSE OF REPRESENTATIVESSENATE
$60,000
Oct 21, 2019
THIRD QUARTER REPORT
United Seating and Mobility, LLC dba Numotion
Providing seating and mobility solutions to consumers with disabilities.
HOUSE OF REPRESENTATIVESSENATE
$60,000
Jul 22, 2019
SECOND QUARTER REPORT
United Seating and Mobility, LLC dba Numotion
Providing seating and mobility solutions to consumers with disabilities.
HOUSE OF REPRESENTATIVESSENATE
$60,000
Apr 17, 2020
FIRST QUARTER REPORT
United Seating and Mobility, LLC dba Numotion
Providing seating and mobility solutions to consumers with disabilities.
HOUSE OF REPRESENTATIVESSENATE
$60,000
Jan 19, 2020
FOURTH QUARTER REPORT
United Seating and Mobility, LLC dba Numotion
Providing seating and mobility solutions to consumers with disabilities.
HOUSE OF REPRESENTATIVESSENATE
$60,000
Apr 22, 2019
FIRST QUARTER REPORT
United Seating and Mobility, LLC dba Numotion
Providing seating and mobility solutions to consumers with disabilities.
HOUSE OF REPRESENTATIVESSENATE
$50,000
Apr 17, 2020
FIRST QUARTER REPORT
Alkermes, Inc.
Global biopharmaceutical company
HOUSE OF REPRESENTATIVESSENATE
$50,000
Apr 17, 2020
FIRST QUARTER REPORT
American Kidney Fund
Charitable non-profit organization that provides support for those with kidney disease
HOUSE OF REPRESENTATIVESSENATE
$50,000
Jan 19, 2020
FOURTH QUARTER REPORT
National Association of Community Health Centers
Providing care to local community residents in rural and urban locations.
HOUSE OF REPRESENTATIVESSENATE
$50,000
Oct 21, 2019
THIRD QUARTER REPORT
National Association of Community Health Centers
Providing care to local community residents in rural and urban locations.
HOUSE OF REPRESENTATIVESSENATE
$50,000
Jan 21, 2020
FOURTH QUARTER TERMINATION
Celgene Corporation
Global biopharmaceutical company
HOUSE OF REPRESENTATIVESSENATE
$50,000
Jan 21, 2020
FOURTH QUARTER REPORT
Alnylam Pharmaceuticals, Inc.
Biopharmaceutical company
HOUSE OF REPRESENTATIVESSENATE
$50,000
Oct 21, 2019
THIRD QUARTER REPORT
Alnylam Pharmaceuticals, Inc.
Biopharmaceutical company
HOUSE OF REPRESENTATIVESSENATE
$50,000
Jan 21, 2020
FOURTH QUARTER REPORT
Celgene Corporation
Global biopharmaceutical company
HOUSE OF REPRESENTATIVESSENATE
$50,000
Oct 21, 2019
THIRD QUARTER REPORT
Alnylam Pharmaceuticals, Inc.
Biopharmaceutical company
HOUSE OF REPRESENTATIVESSENATE
$50,000
Oct 21, 2019
THIRD QUARTER REPORT
American Kidney Fund
Charitable non-profit organization that provides support for those with kidney disease
HOUSE OF REPRESENTATIVESSENATE
$50,000
Apr 17, 2020
FIRST QUARTER REPORT
Alnylam Pharmaceuticals, Inc.
Biopharmaceutical company
HOUSE OF REPRESENTATIVESSENATE
$50,000
Oct 21, 2019
THIRD QUARTER REPORT
Celgene Corporation
Global biopharmaceutical company
HOUSE OF REPRESENTATIVESSENATE
$50,000
Oct 21, 2019
THIRD QUARTER REPORT
Alkermes, Inc.
Global biopharmaceutical company
HOUSE OF REPRESENTATIVESSENATE
$50,000
Jan 21, 2020
FOURTH QUARTER REPORT
Alkermes, Inc.
Global biopharmaceutical company
HOUSE OF REPRESENTATIVESSENATE
$50,000
Jan 21, 2020
FOURTH QUARTER REPORT
American Kidney Fund
Charitable non-profit organization that provides support for those with kidney disease
HOUSE OF REPRESENTATIVESSENATE
$50,000
Apr 22, 2019
FIRST QUARTER REPORT
Celgene Corporation
Global biopharmaceutical company
HOUSE OF REPRESENTATIVESSENATE
$50,000
Jan 21, 2019
FOURTH QUARTER REPORT
Alkermes, Inc.
Global biopharmaceutical company
HOUSE OF REPRESENTATIVESSENATE
$50,000
Jan 21, 2019
FOURTH QUARTER REPORT
National Association of Community Health Centers
Providing care to local community residents in rural and urban locations.
HOUSE OF REPRESENTATIVESSENATE
$50,000
Jan 21, 2019
FOURTH QUARTER REPORT
American Kidney Fund
Charitable non-profit organization that provides support for those with kidney disease
HOUSE OF REPRESENTATIVESSENATE
$50,000
Apr 17, 2020
FIRST QUARTER REPORT
National Association of Community Health Centers
Providing care to local community residents in rural and urban locations.
HOUSE OF REPRESENTATIVESSENATE
$50,000
Apr 22, 2019
FIRST QUARTER REPORT
National Association of Community Health Centers
Providing care to local community residents in rural and urban locations.
HOUSE OF REPRESENTATIVESSENATE
$50,000
Jan 21, 2019
FOURTH QUARTER REPORT
Celgene Corporation
Global biopharmaceutical company
HOUSE OF REPRESENTATIVESSENATE
$50,000
Apr 22, 2019
FIRST QUARTER REPORT
Alkermes, Inc.
Global biopharmaceutical company
HOUSE OF REPRESENTATIVESSENATE
$50,000
Apr 22, 2019
FIRST QUARTER REPORT
American Kidney Fund
Charitable non-profit organization that provides support for those with kidney disease
HOUSE OF REPRESENTATIVESSENATE
$50,000
Apr 22, 2019
FIRST QUARTER REPORT
Alnylam Pharmaceuticals, Inc.
Biopharmaceutical company
HOUSE OF REPRESENTATIVESSENATE
$50,000
Jul 22, 2019
SECOND QUARTER REPORT
Celgene Corporation
Global biopharmaceutical company
HOUSE OF REPRESENTATIVESSENATE
$50,000
Jul 22, 2019
SECOND QUARTER REPORT
Alkermes, Inc.
Global biopharmaceutical company
HOUSE OF REPRESENTATIVESSENATE
$50,000
Jul 22, 2019
SECOND QUARTER REPORT
Alnylam Pharmaceuticals, Inc.
Biopharmaceutical company
HOUSE OF REPRESENTATIVESSENATE
$50,000
Jul 22, 2019
SECOND QUARTER REPORT
American Kidney Fund
Charitable non-profit organization that provides support for those with kidney disease
HOUSE OF REPRESENTATIVESSENATE
$50,000
Apr 17, 2020
FIRST QUARTER REPORT
Bristol-Myers Squibb
Global biopharmaceutical company
HOUSE OF REPRESENTATIVESSENATE
$50,000
Jul 22, 2019
SECOND QUARTER REPORT
National Association of Community Health Centers
Providing care to local community residents in rural and urban locations.
HOUSE OF REPRESENTATIVESSENATE
$40,000
Jul 22, 2019
SECOND QUARTER REPORT
Caris Science Inc
Providing precision medicine services to patients battling aggressive cancers.
HOUSE OF REPRESENTATIVESSENATE
$40,000
Jan 19, 2020
FOURTH QUARTER REPORT
Caris Science Inc
Providing precision medicine services to patients battling aggressive cancers.
HOUSE OF REPRESENTATIVESSENATE
$40,000
Apr 17, 2020
FIRST QUARTER REPORT
Caris Science Inc
Providing precision medicine services to patients battling aggressive cancers.
HOUSE OF REPRESENTATIVESSENATE
$40,000
Apr 22, 2019
FIRST QUARTER REPORT
Caris Science Inc
Providing precision medicine services to patients battling aggressive cancers.
HOUSE OF REPRESENTATIVESSENATE
$40,000
Oct 21, 2019
THIRD QUARTER REPORT
Caris Science Inc
Providing precision medicine services to patients battling aggressive cancers.
HOUSE OF REPRESENTATIVESSENATE
$30,000
Jan 19, 2020
FOURTH QUARTER REPORT
America's Physician Groups
Association representing physician organizations practicing coordinated care
HOUSE OF REPRESENTATIVESSENATE
$30,000
Apr 17, 2020
FIRST QUARTER REPORT
America's Physician Groups
Association representing physician organizations practicing coordinated care
HOUSE OF REPRESENTATIVESSENATE
$30,000
Jan 21, 2019
FOURTH QUARTER REPORT
Alnylam Pharmaceuticals, Inc.
Biopharmaceutical company
HOUSE OF REPRESENTATIVESSENATE
$30,000
Oct 21, 2019
THIRD QUARTER REPORT
America's Physician Groups
Association representing physician organizations practicing coordinated care
HOUSE OF REPRESENTATIVESSENATE
$30,000
Jan 21, 2019
FOURTH QUARTER REPORT
United Seating and Mobility, LLC dba Numotion
Providing seating and mobility solutions to consumers with disabilities.
HOUSE OF REPRESENTATIVESSENATE
$20,000
Jan 21, 2020
FOURTH QUARTER REPORT
Bipartisan Policy Center Action
Bipartisan think tank promoting balanced solutions to national problems.
HOUSE OF REPRESENTATIVESSENATE
$20,000
Oct 21, 2019
THIRD QUARTER REPORT
Bipartisan Policy Center Action
Bipartisan think tank promoting balanced solutions to national problems.
HOUSE OF REPRESENTATIVESSENATE
$20,000
Apr 17, 2020
FIRST QUARTER REPORT
Bipartisan Policy Center Action
Bipartisan think tank promoting balanced solutions to national problems.
HOUSE OF REPRESENTATIVESSENATE
$20,000
Jul 22, 2019
SECOND QUARTER REPORT
Bipartisan Policy Center Action
Bipartisan think tank promoting balanced solutions to national problems.
HOUSE OF REPRESENTATIVESSENATE
$20,000
Apr 22, 2019
FIRST QUARTER REPORT
Bipartisan Policy Center Action
Bipartisan think tank promoting balanced solutions to national problems.
HOUSE OF REPRESENTATIVESSENATE
$20,000
Jan 21, 2019
FOURTH QUARTER REPORT
Caris Science Inc
Providing precision medicine services to patients battling aggressive cancers.
HOUSE OF REPRESENTATIVESSENATE
$20,000
Jan 21, 2019
FOURTH QUARTER REPORT
Bipartisan Policy Center Action
Bipartisan think tank promoting balanced solutions to national problems.
HOUSE OF REPRESENTATIVESSENATE
$5,000
Oct 1, 2019
SECOND QUARTER AMENDMENT
America's Physician Groups
Association representing physician organizations practicing coordinated care
HOUSE OF REPRESENTATIVESSENATE
$0
Jan 21, 2020
REGISTRATION
Bristol-Myers Squibb
Global biopharmaceutical company
HOUSE OF REPRESENTATIVESSENATE
$0
Jul 19, 2019
REGISTRATION
America's Physician Groups
Association representing physician organizations practicing coordinated care
HOUSE OF REPRESENTATIVESSENATE